Atopic Hand and Foot Dermatitis
1 clinical trials · Condition
◉ Watch Atopic Hand and Foot Dermatitis
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis (NCT06921759) | Eli Lilly and Company | 2025-04-21 |
Track Atopic Hand and Foot Dermatitis automatically
Every clearance here is in the API, with alerts when new ones post.